The Evolutionary Impact of Risuteganib in Neurological Disorder Treatment Market and its Role in Modern Therapeutic Strategies The Risuteganib in Neurological Disorder Treatment Market is currently undergoing a significant transformation as clinical researchers delve deeper into the neuroprotective capabilities of integrin-regulating therapies. Risuteganib, primarily known for its application in ophthalmic conditions like macular degeneration, is now being scrutinized for its potential to stabilize mitochondrial function within the central nervous system. This shift in focus is driven by the urgent global need for disease-modifying treatments for neurodegenerative conditions such as Alzheimer’s and Parkinson’s disease. Stakeholders are closely monitoring how this small synthetic peptide can modulate oxidative stress pathways, which are often the root cause of neuronal decay. Ref - https://www.marketresearchfuture.com/reports/risuteganib-in-neurological-disorder-treatment-market-39321